Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada

MP Pomey, S Morgan, J Church… - Journal of health …, 2010 - read.dukeupress.edu
Although the costs of doctors' visits and hospital stays in Canada are covered by national
public health insurance, the cost of outpatient prescription drugs is not. To solve problems of …

[HTML][HTML] The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting …

B Superceanu, SV van Zanten, C Skedgel… - Canadian Journal of …, 2010 - ncbi.nlm.nih.gov
BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that
can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID …

Patient cost sharing: reforms without evidence. Theoretical considerations and empirical findings from industrialized countries

J Holst - 2010 - econstor.eu
International health service research reveals a uniform tendency in practically all
industrialised countries: an increasing shift of costs from solidarity-based financing to private …

Pharmaceutical programs and social policy development: comparing Canada, Australia and the UK

K Boothe - 2010 - open.library.ubc.ca
Canada is the only OECD country that provides broad public health benefits but lacks a
universal, nation-wide system for funding prescription drugs. This puzzle cannot be …

[HTML][HTML] Cost shifting and timeliness of drug formulary decisions in Atlantic Canada

AC Scobie, NJ Mackinnon - Healthcare Policy, 2010 - ncbi.nlm.nih.gov
Context: Our objectives were to investigate the timeliness of formulary decision-making in
Atlantic Canada, including the Common drug Review (CdR) process and the adoption of …